Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 16 of 16 entries
View as:

Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05145907 Org: User:
Start: 12/22/21 End: 12/31/24 Due: 12/31/25

TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03952091 Org: User:
Start: 03/27/19 End: 06/30/24 Due: 06/30/25

A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06984588 Org: User:
Start: 03/28/24 End: 09/30/28 Due: 09/30/29

A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT04633057 Org: User:
Start: 01/25/21 End: 07/31/23 Due: 07/31/24

A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT07005336 Org: User:
Start: 01/09/25 End: 01/09/29 Due: 01/09/30

TJ202 Combined With Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03860038 Org: User:
Start: 01/28/19 End: 01/28/23 Due: 01/28/24

A Study to Evaluate the Safety, Tolerability, and PK Profile of Single and Multiple Doses TJ202 in Patient With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT05140824 Org: User:
Start: 12/30/21 End: 12/14/22 Due: 12/14/23

A Study of Single Drug TJ011133 and Toripalimab Combine Treatment for Advanced Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT05148533 Org: User:
Start: 12/30/21 End: 02/03/23 Due: 02/03/24

A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT05709093 Org: User:
Start: 03/30/23 End: 04/01/24 Due: 04/01/25

A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)

Phase: N/A Priority: Normal
NCT ID: NCT04600817 Org: User:
Start: 12/31/20 End: 12/31/24 Due: 12/31/25

Study of Felzartamab in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06285201 Org: User:
Start: 03/27/24 End: 08/05/24 Due: 08/05/25

A Phase I/II Study of TJ004309 for Advanced Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT04322006 Org: User:
Start: 05/09/20 End: 12/30/25 Due: 12/30/26

Clinical Trial of TJ271 Injection Combined With Pembrolizumab in the Treatment of Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05338580 Org: User:
Start: 12/31/23 End: 12/31/23 Due: 12/31/24

A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic Characteristics, and Immunogenicity of Plonmarlimab in Subjects With Rheumatic and Immunological Disease-associated Haemophagocytic Lymphohistiocytosis (HLH) (Also Known as Macrophage Activation Syndrome (MAS))

Phase: N/A Priority: Normal
NCT ID: NCT07034209 Org: User:
Start: 04/07/23 End: 04/18/25 Due: 04/18/26

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT04202003 Org: User:
Start: 03/25/20 End: 12/15/23 Due: 12/15/24

Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TJ107 in Chinese Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04001075 Org: User:
Start: 02/25/19 End: 09/23/21 Due: 09/23/22